Semaglutide aids in weight loss by mimicking a hormone called GLP-1 (glucagon-like peptide-1) that targets areas of the brain responsible for regulating appetite and food intake
Corinne Rao is a board-certified Internal Medicine physician at Legacy Physicians, specializing in womens health and hormone management
Clinical studies have shown that GLP 1RA medications like semaglutide may affect kidney related adverse effects like kidney stones and severe abdominal pain
Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in parkinsons disease
Because of this, semaglutide should not be used in people with: A personal or family history of medullary thyroid carcinoma (MTC) MEN2 (Multiple Endocrine Neoplasia syndrome type 2) Other serious risks that have been reported with GLP-1 receptor agonists include pancreatitis, gallbladder disease, potential kidney problems, and (in some regulatory guidance) the need to monitor for changes in mood or suicidal thoughts
I said, well, this is, it's an amazing product, but it takes about three months to kick in
